Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CTSH vs MRNA✓SelectedUSD · MRNACTSH vs MRNA performance historyLatest closeAs of-3.42%11/18
Stock and ETF performance explorer

CTSH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-3.3%
MRNA return
+794.5%
Excess return
-797.8%
Maximum drawdown
-56.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.4%-4.8%+1.4%-3.2%
7D-9.6%-20.9%+11.3%-8.8%
30D-12.8%-13.3%+0.5%-12.5%
3M+0.8%+212.6%-211.7%-7.2%
6M+14.0%+309.0%-295.0%+3.1%
YTD-28.5%+567.3%-595.9%-37.3%
1Y-17.3%+689.7%-707.0%-28.2%
3Y-11.6%+157.4%-169.0%-20.5%
5Y-21.9%-21.7%-0.2%-28.5%
All-3.3%+794.5%-797.8%-13.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling